Promoting prostate cancer screening equity: Findings from a quality improvement education initiative implemented in 3 sites.

Authors

null

Ginny Jacobs

AXDEV Global, Inc., Virginia Beach, VA

Ginny Jacobs, Kristen Stevens Hobbs, Keith Crawford, Waseem Hussain, Claire Jean-Simon, Roxanne Leiba Lawrence, Patrice Lazure, Laura Lee Hall, Pam McFadden

Organizations

AXDEV Global, Inc., Virginia Beach, VA, National Minority Quality Forum (NMQF), Center for Sustainable Health Care Quality and Equity (SHC), Washington, DC, Prostate Health Education Network, Inc., Quincy, MA, Luminis Health Primary Care, Annapolis, MD, AXDEV Group, Inc., Brossard, QC, Canada, National Minority Quality Forum, Washington, DC

Research Funding

Pharmaceutical/Biotech Company
Genentech.

Background: Prostate cancer (PC) screening guidelines differ in recommended age at screening and varying emphasis on risk factors (e.g., race, family history), leading to lack of clarity among healthcare providers (HCPs). Research has highlighted a higher risk for Black patients, and the importance for at-risk patients to undergo screening at an earlier age and receive appropriate follow-up. A system-based Quality Improvement Education (QIE) intervention was developed to increase screening and referrals for PC especially among higher risk subgroups. The QIE aimed to increase awareness of the burden and consequences of racial disparities while mobilizing a team-focused approach. Methods: QIE intervention was deployed at 3 practice sites that provide community-based primary care services to Black populations (72% Black patients). The sites differed in patient capacity, staff, challenges faced, and pre-intervention screening practices. Practice assessments were completed pre-intervention by site representatives (n = 3) and individual baseline surveys were filled out by HCPs (n = 24). The 12-week intervention included educational materials from Prostate Health Education Network (PHEN) and deployment of an updated screening protocol within each clinic to raise PC awareness to staff and patients. Post-intervention evaluation was based on qualitative interviews (n = 5) and feedback from the QIE coaches. Patient data from electronic health records (EHR) on PC screening and referrals was collected post-initiative and divided a posteriori into 3 sub-groups, pre, during and post-intervention (n = 6662). Results: QIE led to increased awareness of barriers to access faced by patients from diverse communities. The QIE also led to increased awareness among team members regarding the need for screening at-risk groups at an earlier age and the importance of follow-up with patients. Online education materials made available to HCPs raised patient awareness. Table highlights an increase in PC screening during the intervention, but limited sustainability post-intervention. Interviewees reported increases in patient education, referrals and follow-up action. Conclusions: Increase in percentage of patients screened during the intervention phase was potentially due to added attention during the initiative, while limited sustainability post-intervention might be due to the brief intervention period, reliance on retrospective data and inability to fully leverage EHR data. Based on this project?s learnings, similar initiatives should seek organizational support for data analytics and process documentation to ensure consistent data standards and overall success.

EHR data regarding PC screening across the 3 practice sites pre-, during and post-intervention.

% of patients screened
Pre-
During
Post-
Total
53%
69%
53%
Age 40-45
40%
54%
49%
Black
51%
68%
52%
White
59%
72%
53%

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2022 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session A

Track

Cost, Value, and Policy,Health Care Access, Equity, and Disparities,Patient Experience

Sub Track

Access to Timely Detection and Referral

Citation

J Clin Oncol 40, 2022 (suppl 28; abstr 112)

DOI

10.1200/JCO.2022.40.28_suppl.112

Abstract #

112

Poster Bd #

D11

Abstract Disclosures

Similar Abstracts

Abstract

2021 ASCO Quality Care Symposium

Promotion of prostate cancer screening equity: A quality improvement education initiative.

First Author: Kristen Stevens Hobbs

Abstract

2024 ASCO Quality Care Symposium

Quality improvement of breast and cervical cancer screening satisfaction rate at a resident-led clinic.

First Author: Eunbee Cho

Abstract

2023 ASCO Annual Meeting

Talk, test, and take one click to curb prostate cancer mortality.

First Author: Sandhya Cautha

First Author: Nicole Ann Gay